T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment of preference for numerous malignant and non-malignant hemopathies. The outcome of this approach is significantly hampered by not only graft-versus-host disease (GvHD), but also infections and relapses that may occur because...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudeaux, Pierre, Moirangthem, Ranjita Devi, Bauquet, Aurélie, Simons, Laura, Joshi, Akshay, Cavazzana, Marina, Nègre, Olivier, Soheili, Shabi, André, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300856/
https://www.ncbi.nlm.nih.gov/pubmed/35874778
http://dx.doi.org/10.3389/fimmu.2022.956919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300856/
https://www.ncbi.nlm.nih.gov/pubmed/35874778
http://dx.doi.org/10.3389/fimmu.2022.956919

Ejemplares similares